Endocrinology, Vol 129, 17-21, Copyright © 1991 by Endocrine Society

ARTICLES

11 beta-Hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone

A Naray-Fejes-Toth, CO Watlington and G Fejes-Toth
Department of Physiology, Dartmouth Medical School, Hanover, New Hampshire 03756.

Aldosterone selectivity in mineralocorticoid target tissues has been suggested to be due to 11 beta-hydroxysteroid dehydrogenase (11-OHSD), which, by inactivating the endogenous glucocorticoids cortisol and corticosterone (CS), would allow aldosterone to bind to the mineralocorticoid receptor that has equal affinity for aldosterone and natural glucocorticoids. However, a recent immunohistochemical study failed to colocalize 11-OHSD and mineralocorticoid receptors in the kidney. The goal of this study was to determine 1) whether metabolism of CS occurs in the renal target cells of aldosterone, i.e. in cortical collecting duct cells, and 2) if it does so, whether this activity is sufficient to reduce intracellular CS levels to allow binding of aldosterone to the mineralocorticoid receptor. Cortical collecting duct cells were isolated by solid phase immunoadsorption, with a cell purity of approximately 98%. Metabolism of CS was studied in both freshly isolated cells and primary cultures grown as monolayers on permeable supports. Freshly isolated cells rapidly converted CS to 11-dehydro-CS, which was the only major metabolite detected. In intact collecting duct cells 11-OHSD had an apparent Km for CS of approximately 60 nM, a value more than 100-fold lower than the Km of 11-OHSD in the rat liver, and a maximum velocity of approximately 1.7 x 10(-14) mol/min.1000 cells. In cultured cells, when [3H]CS was applied to one side of the monolayer, almost all radioactivity on the opposite side was 11-dehydro-CS. The cells were able to almost completely metabolize CS passing through them for up to a concentration of 2.5 x 10(-7) M. Carbenoxolone, an inhibitor of 11-OHSD, reduced CS degradation by 88%. Neither freshly isolated nor cultured collecting duct cells converted [3H]11-dehydro-CS back to CS in a significant amount (less than 1%). These data provide functional evidence for 11-OHSD activity in renal aldosterone target cells and indicate that this enzyme might be a collecting duct-specific isoform of 11-OHSD which can sufficiently reduce intracellular CS concentrations to contribute to the apparent mineralocorticoid selectivity of the collecting duct.

This article has been cited by other articles:

				J. C. Geerling and A. D. Loewy 11beta-Hydroxysteroid dehydrogenase 2 vs. transgene: discrepant loci of expression in the adult brain Am J Physiol Renal Physiol, July 1, 2007; 293(1): F440 - F441. [Full Text] [PDF]

				N. Sunak, D. F Green, L. R Abeydeera, L. M Thurston, and A. E Michael Implication of cortisol and 11{beta}-hydroxysteroid dehydrogenase enzymes in the development of porcine (Sus scrofa domestica) ovarian follicles and cysts Reproduction, June 1, 2007; 133(6): 1149 - 1158. [Abstract] [Full Text] [PDF]

				J. Kim, K. A. Temple, S. A. Jones, K. N. Meredith, J. L. Basko, and M. J. Brady Differential Modulation of 3T3-L1 Adipogenesis Mediated by 11beta-Hydroxysteroid Dehydrogenase-1 Levels J. Biol. Chem., April 13, 2007; 282(15): 11038 - 11046. [Abstract] [Full Text] [PDF]

				S. W. Kim, S. de Seigneux, M. C. Sassen, J. Lee, J. Kim, M. A. Knepper, J. Frokiaer, and S. Nielsen Increased apical targeting of renal ENaC subunits and decreased expression of 11betaHSD2 in HgCl2-induced nephrotic syndrome in rats Am J Physiol Renal Physiol, March 1, 2006; 290(3): F674 - F687. [Abstract] [Full Text] [PDF]

				T. Y. Zhang, X. Ding, and R. A. Daynes The Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type I by Lymphocytes Provides a Novel Means for Intracrine Regulation of Glucocorticoid Activities J. Immunol., January 15, 2005; 174(2): 879 - 889. [Abstract] [Full Text] [PDF]

				N. Farman and M.-E. Rafestin-Oblin Multiple aspects of mineralocorticoid selectivity Am J Physiol Renal Physiol, February 1, 2001; 280(2): F181 - F192. [Abstract] [Full Text] [PDF]

				S. Muto Potassium Transport in the Mammalian Collecting Duct Physiol Rev, January 1, 2001; 81(1): 85 - 116. [Abstract] [Full Text] [PDF]

				K. J. Biller, R. J. Unwin, and D. G. Shirley Distal tubular electrolyte transport during inhibition of renal 11{beta}-hydroxysteroid dehydrogenase Am J Physiol Renal Physiol, January 1, 2001; 280(1): F172 - F179. [Abstract] [Full Text] [PDF]

				K. E. Sheppard, S. Hourigan, K. X. Z. Li, and Z. S. Krozowski Novel nuclear corticosteroid binding in rat small intestinal epithelia Am J Physiol Gastrointest Liver Physiol, September 1, 2000; 279(3): G536 - G542. [Abstract] [Full Text] [PDF]

				M. I. New and R. C. Wilson Steroid disorders in children: Congenital adrenal hyperplasia and apparent mineralocorticoid excess PNAS, October 26, 1999; 96(22): 12790 - 12797. [Abstract] [Full Text] [PDF]

				A. Odermatt, P. Arnold, A. Stauffer, B. M. Frey, and F. J. Frey The N-terminal Anchor Sequences of 11beta -Hydroxysteroid Dehydrogenases Determine Their Orientation in the Endoplasmic Reticulum Membrane J. Biol. Chem., October 1, 1999; 274(40): 28762 - 28770. [Abstract] [Full Text] [PDF]

				K. E. Sheppard, K. X. Z. Li, and D. J. Autelitano Corticosteroid receptors and 11beta -hydroxysteroid dehydrogenase isoforms in rat intestinal epithelia Am J Physiol Gastrointest Liver Physiol, September 1, 1999; 277(3): G541 - G547. [Abstract] [Full Text] [PDF]

				A. Naray-Fejes-Toth, C. Canessa, E. S. Cleaveland, G. Aldrich, and G. Fejes-Toth sgk Is an Aldosterone-induced Kinase in the Renal Collecting Duct. EFFECTS ON EPITHELIAL Na+ CHANNELS J. Biol. Chem., June 11, 1999; 274(24): 16973 - 16978. [Abstract] [Full Text] [PDF]

				R. C. Wilson, S. Dave-Sharma, J.-Q. Wei, V. R. Obeyesekere, K. Li, P. Ferrari, Z. S. Krozowski, C. H. L. Shackleton, L. Bradlow, T. Wiens, et al. A genetic defect resulting in mild low-renin hypertension PNAS, August 18, 1998; 95(17): 10200 - 10205. [Abstract] [Full Text] [PDF]

				K. E. Sheppard, K. Khoo, Z. S. Krozowski, and K. X. Z. Li Steroid specificity of the putative DHB receptor: evidence that the receptor is not 11beta HSD Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E124 - E131. [Abstract] [Full Text] [PDF]

				A. Naray-Fejes-Toth and G. Fejes-Toth Extranuclear Localization of Endogenous 11{beta}-Hydroxysteroid Dehydrogenase-2 in Aldosterone Target Cells Endocrinology, June 1, 1998; 139(6): 2955 - 2959. [Abstract] [Full Text] [PDF]

				Y.-J. Liu, Y. Nakagawa, and T. Ohzeki Gene Expression of 11ß-Hydroxysteroid Dehydrogenase Type 1 and Type 2 in the Kidneys of Insulin-Dependent Diabetic Rats Hypertension, March 1, 1998; 31(3): 885 - 889. [Abstract] [Full Text] [PDF]

				A. S. Brem, R. B. Bina, T. King, and D. J. Morris 11{beta}OH-Progesterone Affects Vascular Glucocorticoid Metabolism and Contractile Response Hypertension, September 1, 1997; 30(3): 449 - 454. [Abstract] [Full Text]

				K. X. Z. Li, V. R. Obeyesekere, Z. S. Krozowski, and P. Ferrari Oxoreductase and Dehydrogenase Activities of the Human and Rat 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Enzyme Endocrinology, July 1, 1997; 138(7): 2948 - 2952. [Abstract] [Full Text] [PDF]

				R.-S. Ge, H.-B. Gao, V. L. Nacharaju, G. L. Gunsalus, and M. P. Hardy Identification of a Kinetically Distinct Activity of 11{beta}-Hydroxysteroid Dehydrogenase in Rat Leydig Cells Endocrinology, June 1, 1997; 138(6): 2435 - 2442. [Abstract] [Full Text] [PDF]

				P. C. White, T. Mune, and A. K. Agarwal 11{beta}-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess Endocr. Rev., February 1, 1997; 18(1): 135 - 156. [Abstract] [Full Text]

				Y. H. Lo, M. F. Sheff, S. A. Latif, C. Ribeiro, H. Silver, A. S. Brem, and D. J. Morris Kidney 11{beta}-HSD2 Is Inhibited by Glycyrrhetinic Acid-Like Factors in Human Urine Hypertension, January 1, 1997; 29(1): 500 - 505. [Abstract] [Full Text] [PDF]

				B. Watson, S. M. Bergman, A. Myracle, D. F. Callen, R. T. Acton, and D. G. Warnock Genetic Association of 11ß-Hydroxysteroid Dehydrogenase Type 2 (HSD11B2) Flanking Microsatellites With Essential Hypertension in Blacks Hypertension, September 1, 1996; 28(3): 478 - 482. [Abstract] [Full Text]

				A. Naray-Fejes-Toth and G. Fejes-Toth Subcellular Localization of the Type 211beta -Hydroxysteroid Dehydrogenase. A GREEN FLUORESCENT PROTEIN STUDY J. Biol. Chem., June 28, 1996; 271(26): 15436 - 15442. [Abstract] [Full Text] [PDF]

				G. W. Souness and D. J. Morris 11{alpha}- and 11ß-Hydroxyprogesterone, Potent Inhibitors of 11ß-Hydroxysteroid Dehydrogenase, Possess Hypertensinogenic Activity in the Rat Hypertension, March 1, 1996; 27(3): 421 - 425. [Abstract] [Full Text]

				M. E. Ullian and L. G. Walsh Corticosterone Metabolism and Effects on Angiotensin II Receptors in Vascular Smooth Muscle Circ. Res., October 1, 1995; 77(4): 702 - 709. [Abstract] [Full Text]

				M. Lombes, N. Alfaidy, E. Eugene, A. Lessana, N. Farman, and J.-P. Bonvalet Prerequisite for Cardiac Aldosterone Action : Mineralocorticoid Receptor and 11ß-Hydroxysteroid Dehydrogenase in the Human Heart Circulation, July 15, 1995; 92(2): 175 - 182. [Abstract] [Full Text]

				D Pearce and K. Yamamoto Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element Science, February 19, 1993; 259(5098): 1161 - 1165. [Abstract] [PDF]